Search

everythinglearnresearchcommunity

for

Search:↓

Metabolic syndrome is more common in people with early-onset androgenic alopecia.

Premature hair greying may indicate a higher risk of metabolic problems.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

Polycystic Ovarian Syndrome is common in overweight urban college girls and may increase the risk of heart and metabolic problems.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Obesity can worsen wound healing by negatively affecting the function of stem cells in fat tissue.

Women with PCOS in Sicily show different levels of metabolic problems depending on their PCOS type, with obesity and abnormal lipid profiles being common.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Women with PCOS are more likely to have fatty liver disease and worse metabolic health.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Finasteride can cause lasting sexual, emotional, and cognitive issues, with varying severity.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Insulin resistance is common in PCOS patients and linked to obesity and increased cardiovascular risk.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

High testosterone increases heart disease risk in women with PCOS.

The document concludes that more multidisciplinary research is needed to understand and treat PCOS, a condition that significantly affects women's health and quality of life.

The Korean study confirmed that bariatric surgery is effective for weight loss in Asians.

Young Indian women with PCOS have a higher risk of heart disease, not linked to thyroid function but to higher levels of certain fats and homocysteine.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Greek women with PCOS have a higher risk of metabolic syndrome and are more likely to be overweight compared to healthy controls.